Rich Bendis, Founder, President, and CEO of BioHealth Innovation, Inc. (BHI), and host of the Global BioTalk with Rich Bendis Podcast, will represent BHI and the BioHealth Capital Region at the 2026 BIO International Convention, June 22–24 at the San Diego Convention Center. Throughout the convention, he will meet with companies, investors, and ecosystem leaders to showcase the region’s momentum as one of the country’s fastest-growing life sciences hubs.
Bendis will be available throughout the convention to discuss the BioHealth Capital Region, its proximity to NIH, FDA, and the nation’s top federal research agencies, its deep academic and clinical talent base, and the growing pipeline of commercial-stage and emerging life sciences companies calling the region home.
BHI has spent almost 15 years helping entrepreneurs, research institutions, federal programs, and early-stage funders move promising science closer to market, through technology commercialization, non-dilutive funding strategy, investor readiness, and hands-on entrepreneurial support.
BHI has created a world-class Entrepreneur-in-Residence program used by several federal agencies, university tech transfer offices, and entrepreneurs to deliver personalized commercialization support.
To connect with Rich Bendis at BIO International Convention, reach him at rbendis@biohealthinnovation.org to schedule a meeting at the Maryland Pavilion, Booth No. 4835.
About BioHealth Innovation, Inc.
BioHealth Innovation, Inc. (BHI) is an innovation intermediary that translates market-relevant research into commercial success by connecting management, funding, and markets. BHI supports BioHealth entrepreneurs, companies, research institutions, and federal partners through commercialization guidance, entrepreneur-in-residence support, non-dilutive funding assistance, investor connections, and regional ecosystem development. https://biohealthinnovation.org/
In this episode of BioTalk with Rich Bendis, Jeffrey N. Hausfeld, M.D., Chairman of the Board and Chief Medical Officer of BioFactura Inc., and Darryl Sampey, Ph.D., President and Chief Executive Officer of Capitol Biologics, join the conversation to discuss the launch of Capitol Biologics as BioFactura’s CDMO division.
Rick Wieczorek, President and CEO of the NIH Federal Credit Union and a member of the BioHealth Innovation, Inc. Board of Directors, has been named 2026 CEO of the Year by the MD|DC Credit Union Association.
The BioHealth Capital Region, spanning Maryland, Virginia, and Washington, D.C., has once again been named one of the nation’s Top 3 biopharma clusters by Genetic Engineering & Biotechnology News (GEN), marking the region’s fourth consecutive year in the Top 3.
In this episode of BioTalk with Rich Bendis, Neal Piper, Founder and CEO of Luminoah, returns to share a major milestone in the company’s journey: FDA clearance for Luminoah Flow.
Neal Piper has devoted his career to advancing healthcare and expanding access to life-saving innovation across the U.S., Africa, and Asia. He began in Pfizer’s Neuroscience Division before joining the Global Health Fellows Program, later serving as President of its Alumni Business Network, where he united 350 leaders and scientists to strengthen healthcare systems worldwide. He went on to expand healthcare programs in 18 countries with Population Services International and founded multiple ventures, including a home healthcare company. As the founding CEO of the Presidential Precinct, he empowered emerging and world leaders driving change in government, entrepreneurship, and civil society. Guided by a belief in the power of innovation to improve lives, Neal now leads Luminoah with a mission to create meaningful, lasting change in healthcare.
In this episode of BioTalk with Rich Bendis, Sam Gussman-Toh, Portfolio Manager for the Small Business Program at ARPA-H, joins the conversation to discuss how the agency is creating new pathways for small businesses developing ambitious health technologies.
BioHealth Innovation, Inc. (BHI) congratulates Prashant Panchal, MS, MBA, a member of the BHI Board of Directors, on his recent promotion at AstraZeneca from Director to Senior Director. His new business title is Head of Portfolio, Capacity and Business Operations.
In this episode of BioTalk with Rich Bendis, Jared Smith, MBA, CEcD, President and CEO of the Montgomery County Economic Development Corporation, joins the conversation to discuss his new role leading economic development efforts in one of the nation’s most important biohealth markets.